NEW YORK, Aug. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LifeMD, Inc. (NAS
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (N
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). Such investors are advised to conta
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LifeMD, Inc. (NASD
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD).  Such investors are a
LifeMD saw year-over-year revenue growth for its second quarter slow markedly from the comparable figure in the first quarter. Gross profit margins dipped 200 basis points, versus its year-ago period,
LOS ANGELES--(BUSINESS WIRE)---- $LFMD--LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm.
NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc.
Investors can contact the law firm at no cost to learn more about recovering their losses
NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (N
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) re

LifeMD (LFMD) Q2 Revenue Rises 23%

12:38am, Wednesday, 06'th Aug 2025
LifeMD (LFMD) Q2 Revenue Rises 23%
LifeMD, Inc. (NASDAQ:LFMD ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Pa
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.19 per share a year ago.

LifeMD Reports Second Quarter 2025 Results

04:05pm, Tuesday, 05'th Aug 2025
Total revenue increased 23% year-over-year to $62.2 million; adjusted EBITDA rose 223% to $7.1 million Telehealth revenue increased 30% to $48.6 million; telehealth adjusted EBITDA rose 560% to $3.4 m
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE